FDA Inspection 1268212 — Triumph Pharmaceuticals Inc.
The FDA completed an inspection of Triumph Pharmaceuticals Inc. on Apr 29, 2025 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 29, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Saint Louis, MO (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22795 | 21 CFR 801.20(a) | Label to bear a unique device identifier |
| 419 | 21 CFR 820.20(b) | Lack of or inadequate organizational structure |